vimarsana.com
Home
Live Updates
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence : vimarsana.com
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
/PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven disease...
Related Keywords
Los Angeles ,
California ,
United States ,
Hannah Davis ,
Nicholas Stanzione ,
Michaelj Donovan ,
Clinical Laboratory Improvement Amendments ,
Health System ,
Department Of Pathology ,
Clinical Laboratory Evaluation Program ,
Laboratory Medicine In Los Angeles ,
Laboratory Medicine ,
York State Department Of Health ,
Artificial Intelligence ,
Precisebreast Mount Sinai Hospital ,
Assistant Clinical Professor ,
Chief Medical Officer ,
Morphology Feature ,
Assay Validation Review ,
New York State Department ,
Precisedx ,
vimarsana.com © 2020. All Rights Reserved.